Trial Details
Not RecruitingBasic Information
| Clinical ID | c5598 |
|---|---|
| Identifier | NL-OMON39090 |
| Trial Title | A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS - A3921096 (9002/008), OCTAVE Sustain |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | inflammatory bowel disease Ulcerative Colitis;10017969 |
| Interventions | Subjects will be equally randomized to one of the three treatment groups:Tofacitinib 10 mg BID orally.Tofacitinib 5 mg BID orally.Placebo BID orally. |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | NULL |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | ADULT, ELDER, OLDER_ADULT |
Study Design
| Study Type | Interventional |
|---|---|
| Phase | NULL |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |